CSIMarket Company Name, Ticker, Competitors, else..
 
Catalent Inc   (NYSE: CTLT)
 

CTLT's Market share relative to its competitors, as of Q1 2024

As of Q1 2024 (Revenue in Millions of $)

Date modified: 2026-07-24T01:27:31+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q1 2024		 MARKET SHARE
12 Months
Q1 2024		 MARKET SHARE
MRQ
Q1 2024		 MARKET SHARE
A Quarter Before
Q4 2023
Catalent Inc 4,422.00 7.50% 6.55 % 8.81 %
Thermo Fisher Scientific Inc 44,556.00 75.61% 76.77% 74.48%
Charles River Laboratories International inc 4,027.04 6.83% 6.43% 6.74%
Aptargroup inc 3,872.74 6.57% 6.57% 6.65%
Evotec Se 882.98 1.50% 1.50% 0.00%
Corcept Therapeutics Inc 769.10 1.31% 1.64% 1.12%
5 more competitors available

Sign in to see all competitors for Catalent Inc .

Sign In Create Free Account



CTLT's Market share relative to its competitors, as of Q1 2024 within the Major Pharmaceutical Preparations Industry
As of Q1 2024



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2024		 MARKET SHARE
12 Months Ending
Q4 2023		 MARKET SHARE
MRQ
Q1 2024		 MARKET SHARE

Q4 2023
Catalent Inc 68.81% 68.78% 64.46 % 73.05 %
Evotec Se 13.74% 14.01% 13.74% 14.01%
Corcept Therapeutics Inc 11.97% 11.95% 16.14% 9.26%
Cryoport inc 2.85% 2.77% 3.09% 2.68%
Avid Bioservices Inc 2.34% 2.24% 2.11% 2.26%
Immunoprecise Antibodies Ltd 0.29% 0.25% 0.29% 0.25%



CTLT's Market share relative to its competitors, as of Q1 2024 within the Healthcare Sector
As of Q1 2024



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2024		 MARKET SHARE
12 Months Ending
Q4 2023		 MARKET SHARE
MRQ
Q1 2024		 MARKET SHARE

Q4 2023
Catalent Inc 42.13% 42.02% 39.30 % 46.67 %
Charles River Laboratories International inc 38.37% 38.51% 38.57% 35.72%
Evotec Se 8.41% 8.56% 8.41% 8.56%
Corcept Therapeutics Inc 7.33% 7.30% 9.84% 5.92%
Cryoport inc 1.74% 1.69% 1.88% 1.71%
Avid Bioservices Inc 1.43% 1.37% 1.29% 1.44%
3 more companies available

Sign in to see all sector competitors for Catalent Inc .

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Catalent Inc's market divisions, geographic dispersion, segments, products, and services, visit Catalent Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.